ClinConnect ClinConnect Logo
Search / Trial NCT06752265

Application for Sexual Abuse Prevention Based On Empowerment of Parents And School Teachers

Launched by UNIVERSITAS PADJADJARAN · Dec 21, 2024

Trial Information

Current as of November 13, 2025

Enrolling by invitation

Keywords

Children Application Sexual Abuse Prevention Adolescents

ClinConnect Summary

This study is testing whether the PERAN SADAR app can help parents, teachers, and children learn to prevent sexual abuse. It is being done with elementary school students ages 10 to 12 in Sumedang, West Java, Indonesia, and about 88 participants are planned. Everyone in the study receives the PERAN SADAR app (there is no separate comparison group).

Participants will use the app for nine days, with daily lessons delivered as videos, songs, documents, and other content. Over the following month, parents at home and teachers at school are encouraged to share safety information with children. Children will take a knowledge quiz before and after the program; parents and teachers will answer questions about knowledge, attitudes toward prevention, self-awareness, and how they communicate about safety, also before and after. The study started in December 2024 and aims to finish around December 2025; results are not yet available. It is not regulated by the U.S. FDA.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • student at elementary school
  • Exclusion Criteria:
  • sick, refuse to join

About Universitas Padjadjaran

Universitas Padjadjaran, a prestigious academic institution in Indonesia, is dedicated to advancing medical research and clinical trials that contribute to the improvement of healthcare outcomes. With a strong emphasis on interdisciplinary collaboration and innovation, the university harnesses its extensive resources and expertise to conduct rigorous studies aimed at addressing pressing health challenges. Through its commitment to ethical research practices and community engagement, Universitas Padjadjaran plays a pivotal role in fostering evidence-based medicine and enhancing the quality of life for diverse populations.

Locations

Sumedang, Jawa Barat, Indonesia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported